Home> News

Shuanglong enterprise enters development fast lane

english.guiyang.gov.cn |Updated: 2025-06-25 16:56:28

From January to May, Guizhou Liangji Pharmaceutical Co in Guizhou Shuanglong Airport Economic Zone achieved a production value of 145.16 million yuan ($20.24 million), a year-on-year increase of 44.5 percent. Its revenue was 117.28 million yuan, a year-on-year increase of 22.38 million yuan.

Liangji Pharmaceutical Co is a modern high-tech enterprise of traditional Chinese medicine in the economic zone that integrates medicine research and development, planting, production, and sales. It mainly deals in oral and external traditional Chinese patent medicines characterized by Miao medicine. As of now, it has 43 drug approval numbers, eight exclusive varieties, and 10 GMP production lines.

Since its establishment, the company has been driven by technological innovation, continuously increasing R&D investment, building a comprehensive intellectual property system, ensuring the technological leadership and market competitiveness of its core products, and enabling the enterprise to reach new heights.

The company generated a revenue of 203.51 million yuan in 2023, and 234.28 million yuan in 2024. The revenue of 2025 is expected to reach 300 million yuan.

By the end of 2024, the economic zone was home to 398 pharmaceutical enterprises, including 22 production enterprises and 376 sales enterprises, including nine above a designated size, which have achieved a total industrial output value of over 600 million yuan this year.

Liangji Pharmaceutical is now undergoing phase one expansion and renovation, and phase two plans to expand and renovate storage centers, formulation workshops, and extraction workshops. Once completed, the annual output value of the company will increase 1 billion to 1.5 billion yuan in the next 5 years, with an annual tax revenue of about 70 million to 110 million yuan, as well as 100 new jobs.


Guiyang China © 2025 The Guiyang Municipal People's Government. All Rights Reserved.
Presented by China Daily.
黔ICP备05001922号-3
站长统计

Share - Wechat